Literature DB >> 1748040

Effects of stimulation and inhibition of acid secretion on gastric damage induced by platelet-activating factor.

J M Piqué1, R M Pérez Ayuso, J Bilbao, J Terés.   

Abstract

Intravenous administration of platelet-activating factor (PAF) induces extensive damage in rat gastric mucosa. The aim of the present study was to examine whether the presence or absence of acid in the gastric lumen could modify the PAF-induced gastric damage. The effects of inhibition of basal and pentagastrin-stimulated acid secretion by ranitidine on the deep histological gastric damage induced by 30 min of infusion of PAF (100 ng/kg/min) were assessed by using a histological score. Inhibition of basal gastric acid secretion did not prevent the histological gastric damage induced by PAF. Stimulation of gastric acid secretion by pentagastrin significantly increased PAF-induced gastric damage, and this effect was reversed by a dose of ranitidine that returns acid secretion to baseline levels. This acid-related damage was confined to the deep mucosa, since scanning electron microscope analysis ruled out an additional surface damage in PAF-infused rats when gastric acid was stimulated. The data indicate that a certain amount of acid may worsen the deep gastric mucosal damage induced by PAF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748040     DOI: 10.1007/bf01296615

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock.

Authors:  Z Terashita; G L Stahl; A M Lefer
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

2.  Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor.

Authors:  J L Wallace; B J Whittle
Journal:  Eur J Pharmacol       Date:  1986-05-13       Impact factor: 4.432

3.  Gastric mucosal blood flow response to stimulation and inhibition of gastric acid secretion.

Authors:  J M Pique; F W Leung; H W Tan; E Livingston; O U Scremin; P H Guth
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

4.  Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis.

Authors:  J P Cueva; W Hsueh
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

5.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

Authors:  T W Doebber; M S Wu; J C Robbins; B M Choy; M N Chang; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-03-29       Impact factor: 3.575

6.  Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients.

Authors:  H J Priebe; J J Skillman; L S Bushnell; P C Long; W Silen
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

7.  Potent ulcerogenic actions of platelet-activating factor on the stomach.

Authors:  A C Rosam; J L Wallace; B J Whittle
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

8.  Pentagastrin and gastric mucosal blood flow.

Authors:  L Holm-Rutili; T Berglindh
Journal:  Am J Physiol       Date:  1986-05

9.  Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants.

Authors:  J L Wallace; B J Whittle
Journal:  Prostaglandins       Date:  1986-05

10.  Indomethacin potentiates endotoxin-induced blood flow reduction and histological injury in rat gastric mucosa.

Authors:  J M Piqué; Y Yonei; B J Whittle; F W Leung; P H Guth
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

View more
  1 in total

1.  Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells.

Authors:  I L Beales
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.